TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 78 filers reported holding TRANSLATE BIO INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $23,000 | +76.9% | 1,416 | +94.2% | 0.00% | 0.0% |
| Q4 2020 | $13,000 | -35.0% | 729 | -50.2% | 0.00% | -50.0% |
| Q3 2020 | $20,000 | -25.9% | 1,463 | -4.1% | 0.00% | -33.3% |
| Q2 2020 | $27,000 | – | 1,526 | +2443.3% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 60 | -99.4% | 0.00% | -100.0% |
| Q2 2018 | $128,000 | – | 10,128 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,437,601 | $24,376,000 | 11.53% |
| DAFNA Capital Management LLC | 151,739 | $1,517,000 | 0.62% |
| Bain Capital Public Equity Management, LLC | 738,543 | $7,385,000 | 0.52% |
| Baupost Group | 6,491,287 | $62,393,000 | 0.48% |
| Rock Springs Capital Management LP | 1,009,179 | $10,092,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 276,639 | $2,766,000 | 0.32% |
| Cormorant Asset Management, LP | 454,550 | $4,546,000 | 0.30% |
| Artal Group S.A. | 600,000 | $6,000,000 | 0.16% |
| Perceptive Advisors | 500,000 | $5,000,000 | 0.13% |
| ArrowMark Colorado Holdings LLC | 367,744 | $3,677,000 | 0.03% |